Sign in to follow
Search Results

0 results for 'Novo Nordisk'

You can use to get even better search results
February 08, 2024 | The American Lawyer

US Firms Line Up Behind $16B Three-Way Drug Manufacturing Deal

Skadden, Goodwin Procter and Jones Day are behind the $16.5 billion acquisition of an American pharmaceutical company by the holding company of Novo Nordisk, maker of weight-loss drug Wegovy and Type 2 diabetes shot Ozempic.
3 minute read
February 05, 2024 | The American Lawyer

Deal Watch: Hogan Lovells and Wachtell Land Big Sports Deals

Professional and college sports were center stage this past week for lawyers.
7 minute read
February 05, 2024 | New York Law Journal

US Judge Ends Antitrust Claim Alleging Conspiracy to Manipulate Prices of Insulin Products

Chief Judge Elizabeth Wolford of U.S. District Court, Western District in Rochester wrote that the plaintiffs failed to present a viable claim under the Sherman Act.
4 minute read
February 02, 2024 | The Legal Intelligencer

A Pennsylvania Judge Will Oversee Lawsuits Targeting Weight Loss Drug Ozempic

On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered 55 cases filed against Eli Lilly and Novo Nordisk over Ozempic, Mounjaro and other medications be coordinated into multidistrict litigation.
3 minute read
Law Journal Press | Digital Book Wrongful Use of Civil Proceedings and Related Torts in Pennsylvania, Second Edition Authors: George Bochetto, David P. Heim, John A. O’Connell, Robert S. Tintner View this Book

View more book results for the query "Novo Nordisk"

January 29, 2024 | Law.com

Post-Pandemic Rise in High-Dollar Verdicts Shows Signs of Sticking: The Morning Minute

The news and analysis you need to start your day.
4 minute read
January 26, 2024 | Law.com

Did Weight-Loss Wonder Drugs Fail to Warn? 'This Case Is Very Strong Right Now'

About 50 lawsuits so far target Novo Nordisk and Eli Lilly over Type 2 diabetes medications Ozempic, Mounjaro and other medications. Lawyers anticipate 10,000 to 20,000 cases.
7 minute read
January 22, 2024 | Daily Business Review

Too Good to Be True? Ozempic Lawsuit Moves Forward as Gastrointestinal Issues Surface

Ozempic isn't without side effects, however, and several patients who have experienced severe complications from the drug are now suing Novo Nordisk and Eli Lilly on allegations that the pharmaceutical companies misled doctors on the drugs' potential risks.
5 minute read
January 19, 2024 | New Jersey Law Journal

Big Law Squares Off in Battle Over Prescription Drug Prices

Courts have consistently rejected challenges under the Takings Clause to federal health care programs that seek to limit costs, according to an amicus curiae brief by a panel of nine nationally recognized experts in Medicare and medical finance.
5 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources